Micronoma in the News

The Microbiome and Human Cancer

The Microbiome and Human Cancer

Separating microbes and cancers The role of microorganisms in causing and sustaining cancers has been in dispute for centuries. Through the lens of gut- and tumor-associated microbes, Sepich-Poore et al. review our current understanding of the microbiota in cancer,...

Micronoma Closes $3.5M Convertible Debt Financing Round

Micronoma Closes $3.5M Convertible Debt Financing Round

Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full story.

Micronoma Expands Executive Team and Operations

Micronoma Expands Executive Team and Operations

SAN DIEGO, Calif., Nov. 5, 2020 /PRNewswire/ -- Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique microbiome-based assay, today announced their company expansion with three key executive...

Prime Time for the Microbiome

Prime Time for the Microbiome

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.

Micronoma Launches with $3 Million Seed Funding

Micronoma Launches with $3 Million Seed Funding

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Read More.

Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More

Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More

The road of drug development is rife with detours and disappointments but Seres Therapeutics showed this week that course corrections can work. Four years after its microbiome therapy failed in a mid-stage study, the company reported early positive data from a pivotal...

Start-Up Developing Microbial Cancer Detection Tests

Start-Up Developing Microbial Cancer Detection Tests

13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity...

Micronoma Finds $3M For Early Cancer Detection

Micronoma Finds $3M For Early Cancer Detection

San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round. The funding was led by SymBiosis, LLc. According to the company,

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or contact us.

Micronoma
6342 Ferris Square
San Diego, CA 92121